Literature DB >> 3218956

Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.

S C Mann1, P A Andrews, S B Howell.   

Abstract

We conducted studies to determine whether the cisplatin (DDP)-resistant human ovarian carcinoma cell line designated 2008/DDP has membrane changes which could slow the passive diffusion of the drug into cells, thereby accounting for the observed reduction in DDP accumulation in 2008/DDP cells compared to the sensitive parental 2008 cells. To this end, we compared three indicators of membrane lipid composition and fluidity in the resistant and sensitive cells. In a comparison of major membrane lipid classes, the resistant line had a 17% increase in phosphatidyl choline, and an 11% increase in phosphatidyl ethanolamine relative to the sensitive line. There were no differences in the other major phospholipids or in the free cholesterol content of the cell lines. Secondly, results of fluorescence polarization measurements on whole cells of each line using the plasma membrane specific probe trimethylammonium diphenylhexatriene revealed no difference between the cell lines at both 28 degrees C and 37 degrees C. Finally, an examination of the temperature-dependence of DDP accumulation over 1 h produced Arrhenius plots of similar shape in 2008 and 2008/DDP cells. Both plots were linear from 40 degrees C down to a break point between 4 degrees C and 12 degrees C. The Q10's for DDP accumulation from 30 degrees C to 40 degrees C were greater than 2 in each cell line and were not significantly different. Results of these 3 comparisons point to substantial similarity in the bulk membrane lipid composition and fluidity of the two cell lines. We conclude that decreased DDP accumulation in our resistant cells is not due to membrane changes that would be expected to retard passive diffusion of the drug into the cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3218956

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  More pronounced salt dependence and higher reactivity for platination of the hairpin r(CGCGUUGUUCGCG) compared with d(CGCGTTGTTCGCG).

Authors:  Margareta Hägerlöf; Pal Papsai; Christine S Chow; Sofi K C Elmroth
Journal:  J Biol Inorg Chem       Date:  2006-09-05       Impact factor: 3.358

2.  Understanding Cell Penetration of Cyclic Peptides.

Authors:  Patrick G Dougherty; Ashweta Sahni; Dehua Pei
Journal:  Chem Rev       Date:  2019-05-14       Impact factor: 60.622

3.  Differential properties of cisplatin and tetraplatin with respect to cytotoxicity and perturbation of cellular glutathione levels.

Authors:  M R Müller; K A Wright; P R Twentyman
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Potentiation of cytotoxicity of mitomycin C by a polyacetylenic alcohol, panaxytriol.

Authors:  H Matsunaga; M Katano; T Saita; H Yamamoto; M Mori
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Transient cisplatin-resistant murine fibrosarcoma cell characterized by increased metallothionein content.

Authors:  H Eichholtz-Wirth; R Born; G Reidel; B Hietel
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cells.

Authors:  P Naredi; D D Heath; R E Enns; S B Howell
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

Review 7.  Cellular accumulation of the anticancer agent cisplatin: a review.

Authors:  D P Gately; S B Howell
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

8.  Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin.

Authors:  J A Plumb; W Luo; D J Kerr
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

9.  Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.

Authors:  Alois Kozubík; Alena Vaculová; Karel Soucek; Jan Vondrácek; Jaroslav Turánek; Jirina Hofmanová
Journal:  Met Based Drugs       Date:  2008

10.  Pressure tuning infrared spectroscopic study of cisplatin-induced structural changes in a phosphatidylserine model membrane.

Authors:  K D Taylor; R Goel; F H Shirazi; M Molepo; P Popovic; D J Stewart; P T Wong
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.